Published On : Mon, Apr 12th, 2021

Sputnik-V vaccine gets nod for use in India

Advertisement

Russia’s Covid vaccine Sputnik-V has been cleared for emergency use approval in India by a committee of experts in the middle of a record spike in virus cases in the country.

If approved by regulator DGCI, this will become the third vaccine to be used in India after Serum Institute of India’s Covishield – developed by Oxford-AstraZeneca – and Bharat Biotech’s Covaxin.

Gold Rate
28 Jan 2026
Gold 24 KT ₹ 1,64,400/-
Gold 22 KT ₹ 1,52,900 /-
Silver/Kg ₹ 3,72,000 /-
Platinum ₹ 60,000/-
Recommended rate for Nagpur sarafa Making charges minimum 13% and above

Sputnik-V, manufactured in India by Dr Reddy’s, has the highest effectiveness – 91.6 per cent — after the Moderna and Pfizer shots.

GET YOUR OWN WEBSITE
FOR ₹9,999
Domain & Hosting FREE for 1 Year
No Hidden Charges
Advertisement
Advertisement